Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
N Engl J Med ; 386(9): 861-868, 2022 03 03.
Article in English | MEDLINE | ID: mdl-35235727

ABSTRACT

Melioidosis, caused by the bacterium Burkholderia pseudomallei, is an uncommon infection that is typically associated with exposure to soil and water in tropical and subtropical environments. It is rarely diagnosed in the continental United States. Patients with melioidosis in the United States commonly report travel to regions where melioidosis is endemic. We report a cluster of four non-travel-associated cases of melioidosis in Georgia, Kansas, Minnesota, and Texas. These cases were caused by the same strain of B. pseudomallei that was linked to an aromatherapy spray product imported from a melioidosis-endemic area.


Subject(s)
Aromatherapy/adverse effects , Burkholderia pseudomallei/isolation & purification , Disease Outbreaks , Melioidosis/epidemiology , Aerosols , Brain/microbiology , Brain/pathology , Burkholderia pseudomallei/genetics , COVID-19/complications , Child, Preschool , Fatal Outcome , Female , Genome, Bacterial , Humans , Lung/microbiology , Lung/pathology , Male , Melioidosis/complications , Middle Aged , Phylogeny , Shock, Septic/microbiology , United States/epidemiology
2.
Emerg Infect Dis ; 27(9): 2323-2332, 2021 09.
Article in English | MEDLINE | ID: mdl-34193337

ABSTRACT

We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use of public transportation was more common. Within the household, presumed transmission was highest from older (>65 years) index case-patients and from children to parents, independent of index case-patient age. These findings may inform guidance for limiting transmission and emphasize the value of testing to identify community-acquired infections.


Subject(s)
COVID-19 , Aged , COVID-19/transmission , Child , DNA Viruses , Family Characteristics , Humans , SARS-CoV-2 , United States/epidemiology
3.
MMWR Morb Mortal Wkly Rep ; 70(14): 505-509, 2021 Apr 09.
Article in English | MEDLINE | ID: mdl-33830980

ABSTRACT

Psittacosis is typically a mild febrile respiratory illness caused by infection with the bacterium Chlamydia psittaci and usually transmitted to humans by infected birds (1). On average, 11 psittacosis cases per year were reported in the United States during 2000-2017. During August-October 2018, the largest U.S. psittacosis outbreak in 30 years (82 cases identified*) occurred in two poultry slaughter plants, one each in Virginia and Georgia, that shared source farms (2). CDC used C. psittaci real-time polymerase chain reaction (PCR) to test 54 human specimens from this outbreak. This was the largest number of human specimens from a single outbreak ever tested for C. psittaci using real-time PCR, which is faster and more sensitive than commercially available serologic tests. This represented a rare opportunity to assess the utility of multiple specimen types for real-time PCR detection of C. psittaci. C. psittaci was detected more frequently in lower respiratory specimens (59% [10 of 17]) and stool (four of five) than in upper respiratory specimens (7% [two of 28]). Among six patients with sputum and nasopharyngeal swabs tested, C. psittaci was detected only in sputum in five patients. Cycle threshold (Ct) values suggested bacterial load was higher in lower respiratory specimens than in nasopharyngeal swabs. These findings support prioritizing lower respiratory specimens for real-time PCR detection of C. psittaci. Stool specimens might also have utility for diagnosis of psittacosis.


Subject(s)
Chlamydophila psittaci/isolation & purification , Disease Outbreaks , Mass Screening/methods , Psittacosis/diagnosis , Real-Time Polymerase Chain Reaction , Adult , Chlamydophila psittaci/genetics , Feces/microbiology , Female , Georgia/epidemiology , Humans , Male , Middle Aged , Psittacosis/epidemiology , Sputum/microbiology , Virginia/epidemiology , Young Adult
4.
J Infect Dis ; 221(8): 1371-1378, 2020 03 28.
Article in English | MEDLINE | ID: mdl-31267128

ABSTRACT

BACKGROUND: Since 2000, the reported prevalence of tick-borne spotted fever rickettsiosis has increased considerably. We compared the level of antibody reactivity among healthy blood donors from 2 widely separated regions of the United States and evaluated the impact of antibody prevalence on public health surveillance in one of these regions. METHODS: Donor serum samples were evaluated by indirect immunofluorescence antibody assay to identify immunoglobulin G (IgG) antibodies reactive with Rickettsia rickettsii. The Georgia Department of Public Health (GDPH) analyzed characteristics of cases from 2016 surveillance data to evaluate the utility of laboratory surveillance for case assessment. RESULTS: Of the Georgia donors (n = 1493), 11.1% demonstrated antibody titers reactive with R. rickettsii at titers ≥64, whereas 6.3% of donors from Oregon and Washington (n = 1511) were seropositive. Most seropositive donors had a titer of 64; only 3.1% (n = 93) of all donors had titers ≥128. During 2016, GDPH interviewed 243 seropositive case patients; only 28% (n = 69) met inclusion criteria in the national case definition for spotted fever rickettsiosis. CONCLUSIONS: These findings suggest that a single IgG antibody titer is an unreliable measure of diagnosis and could inaccurately affect surveillance estimates that define magnitude and clinical characteristics of Rocky Mountain spotted fever and other spotted fever rickettsioses.


Subject(s)
Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Rickettsia rickettsii/immunology , Rocky Mountain Spotted Fever/immunology , Rocky Mountain Spotted Fever/microbiology , Spotted Fever Group Rickettsiosis/immunology , Spotted Fever Group Rickettsiosis/microbiology , Adolescent , Adult , Aged , Animals , Arachnid Vectors/microbiology , Blood Donors , Female , Georgia , Humans , Immunoglobulin G/immunology , Immunologic Tests/methods , Male , Middle Aged , Oregon , Rickettsia Infections/immunology , Rickettsia Infections/microbiology , United States , Washington , Young Adult
5.
MMWR Morb Mortal Wkly Rep ; 69(28): 904-908, 2020 Jul 17.
Article in English | MEDLINE | ID: mdl-32673296

ABSTRACT

Coronavirus disease 2019 (COVID-19) was first detected in the United States in January 2020 (1), and by mid-July, approximately 3.4 million cases had been reported in the United States (2). Information about symptoms among U.S. COVID-19 patients is limited, especially among nonhospitalized patients. To better understand symptom profiles of patients with laboratory-confirmed COVID-19 in the United States, CDC used an optional questionnaire to collect detailed information on a convenience sample of COVID-19 patients from participating states. Symptom data were analyzed by age group, sex, hospitalization status, and symptom onset date relative to expansion of testing guidelines on March 8, 2020 (3). Among 164 symptomatic patients with known onset during January 14-April 4, 2020, a total of 158 (96%) reported fever, cough, or shortness of breath. Among 57 hospitalized adult patients (aged ≥18 years), 39 (68%) reported all three of these symptoms, compared with 25 (31%) of the 81 nonhospitalized adult patients. Gastrointestinal (GI) symptoms and other symptoms, such as chills, myalgia, headache, and fatigue, also were commonly reported, especially after expansion of testing guidelines. To aid prompt recognition of COVID-19, clinicians and public health professionals should be aware that COVID-19 can cause a wide variety of symptoms.


Subject(s)
Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Symptom Assessment , Adolescent , Adult , Aged , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , Child , Child, Preschool , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Cough/virology , Dyspnea/virology , Female , Fever/virology , Hospitalization/statistics & numerical data , Humans , Infant , Male , Middle Aged , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , SARS-CoV-2 , Severity of Illness Index , United States/epidemiology , Young Adult
6.
Emerg Infect Dis ; 25(11): 2143-2145, 2019 11.
Article in English | MEDLINE | ID: mdl-31625859

ABSTRACT

During August-October, 2018, an outbreak of severe respiratory illness was reported among poultry slaughter plant workers in Virginia and Georgia, USA. A multiorganizational team investigated the cause and extent of illness, determined that the illness was psittacosis, and evaluated and recommended controls for health hazards in the workplace to prevent additional cases.


Subject(s)
Abattoirs , Psittacosis/epidemiology , Adult , Georgia/epidemiology , History, 21st Century , Humans , Middle Aged , Psittacosis/history , Psittacosis/microbiology , Public Health Surveillance , Virginia/epidemiology , Young Adult
7.
Open Forum Infect Dis ; 8(10): ofab473, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34660837

ABSTRACT

Automated identification systems may misidentify Brucella, the causative agent of brucellosis, which may be re-emerging in the United States as the result of an expanding feral swine population. We present a case of Brucella suis likely associated with feral swine exposure that was misidentified as Ochrobactrum anthropi, a phylogenetic relative.

SELECTION OF CITATIONS
SEARCH DETAIL